SciVision Biotech Inc (1786) — Capital Reinvestment Ratio
Latest as of September 2025:
2.11x
SciVision Biotech Inc (1786) has a Capital Reinvestment Ratio of 2.11x as of September 2025, meaning it reinvests 2% of its operating cash flow (NT$15.41 Million) in capital expenditures (NT$32.58 Million). See cash generation quality of SciVision Biotech Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
2.11x
Capex / Operating Cash Flow
Operating Cash Flow
NT$15.41 Million
TWD
Capital Expenditures
NT$32.58 Million
TWD
Data as of
Sep 2025
Most recent filing
SciVision Biotech Inc Capital Reinvestment Ratio (2010–2025)
This chart tracks SciVision Biotech Inc's Capital Reinvestment Ratio across 16 annual periods.
Annual Capital Reinvestment Ratio for SciVision Biotech Inc (2010–2025)
Year-by-year Capital Reinvestment Ratio for SciVision Biotech Inc from 2010 to 2025. For live market cap and broader valuation context, see 1786 market cap.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.82x | NT$123.99 Million | NT$101.53 Million | ▲ +533.5% |
| 2024 | 0.13x | NT$269.87 Million | NT$34.88 Million | ▲ +136.8% |
| 2023 | 0.05x | NT$272.01 Million | NT$14.84 Million | ▼ -35.0% |
| 2022 | 0.08x | NT$178.21 Million | NT$14.96 Million | ▼ -67.9% |
| 2021 | 0.26x | NT$98.51 Million | NT$25.77 Million | ▼ -50.5% |
| 2020 | 0.53x | NT$126.47 Million | NT$66.84 Million | ▼ -46.5% |
| 2019 | 0.99x | NT$204.40 Million | NT$202.03 Million | ▲ +15.8% |
| 2018 | 0.85x | NT$111.70 Million | NT$95.32 Million | ▼ -95.8% |
| 2017 | 20.29x | NT$15.98 Million | NT$324.26 Million | ▲ +237.3% |
| 2016 | 6.02x | NT$38.29 Million | NT$230.32 Million | ▲ +46.0% |
| 2015 | 4.12x | NT$49.81 Million | NT$205.27 Million | ▼ -94.0% |
| 2014 | 68.18x | NT$1.85 Million | NT$126.27 Million | ▲ +9062.9% |
| 2013 | 0.74x | NT$37.27 Million | NT$27.74 Million | ▲ +182.3% |
| 2012 | 0.26x | NT$51.52 Million | NT$13.58 Million | ▼ -53.2% |
| 2011 | 0.56x | NT$37.13 Million | NT$20.91 Million | ▼ -83.3% |
| 2010 | 3.38x | NT$6.85 Million | NT$23.13 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow